Y-mAbs Therapeutics, Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Welcome everyone to the 39th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Tessa Romero and Matt Bannon from the team. Our next presenting company is Y-mAbs, and speaking on behalf of the company, we have CEO, Claus Møller. Before I turn it over to Claus, I just want to remind those on the webcast that you can submit a question via the ask the question feature in the portal, and I'm happy to ask a question on your behalf.
With that, I'll turn it over to you, Claus.
¸ -
Thank you very much, Anupam, and thank you, everybody, for listening into today to our company presentation for the JPMorgan Conference, January 2021. You should have access to the slide deck, and I'm going to go to the disclaimer and make sure that you have all paid attention to that. Our mission in Y-mAbs is to become the world leader in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |